Search

everythinglearnresearchcommunity

for

Search:↓

Intravenous methylprednisolone helped over half of alopecia areata patients regrow hair, but many relapsed.

Excimer light therapy is more effective than low level laser therapy for treating alopecia areata.

New steroids were patented as effective for treating acne, hair loss, and other conditions related to hormones.

Certain medications can cause serious side effects, so it's important to report them.

Minoxidil was promising for treating male and female pattern baldness in 1994, but more research on genetics and other treatments was needed.

Combining triamcinolone acetonide and immunotherapy can help regrow hair in some alopecia totalis patients.

Combining fat grafts with botulinum toxin helps improve Raynaud's symptoms.

Vitexin Compound 1 may help reduce skin aging caused by UVA light.

Acitretin moderately improved skin and eye issues but not hair loss or light sensitivity in a 3-year-old with IFAP syndrome.

Tofacitinib helps hair regrow in some kids with severe alopecia areata, but more research is needed on long-term effects.

Oral dutasteride is effective and safe for treating frontal fibrosing alopecia.

NTF gel improves finasteride delivery for hair loss treatment, reducing side effects.

Allopregnanolone can reduce gut inflammation and normalize neurotransmitter levels after finasteride withdrawal.

Retinoids may help treat lupus nephritis and reduce steroid use.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Mixing calcipotriol with a steroid is almost as effective as using a steroid alone for alopecia areata and has fewer side effects.

Low-dose methotrexate effectively regrows hair in many alopecia areata patients but can cause some side effects.

Ablative fractional resurfacing could improve how well topical drugs penetrate the skin, but more research is needed to fine-tune the method.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

A specific gene variant causes severe skin issues and increases infection risk, requiring careful medical monitoring.

The study found that a specific type of hair loss is increasingly common in premenopausal women and can be effectively diagnosed and treated with various medications.

People with Alopecia areata have higher levels of certain T regulatory cells in their blood.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Combining pentoxifylline with corticosteroids improves alopecia areata treatment.

Baricitinib was effective in treating both early and late onset alopecia areata.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.